|
TRMT61B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.428130E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.070160E-01 |
| Normal-vs-Stage2 |
2.586000E-01 |
| Normal-vs-Stage3 |
1.48369999997122E-06 |
| Normal-vs-Stage4 |
4.74499994851385E-10 |
| Stage1-vs-Stage2 |
8.965600E-01 |
| Stage1-vs-Stage3 |
5.586700E-04 |
| Stage1-vs-Stage4 |
3.27329999771919E-08 |
| Stage2-vs-Stage3 |
1.975690E-02 |
| Stage2-vs-Stage4 |
7.647300E-04 |
| Stage3-vs-Stage4 |
8.061800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023230E-04 |
| Normal-vs-AfricanAmerican |
5.450400E-02 |
| Normal-vs-Asian |
8.772000E-01 |
| Caucasian-vs-AfricanAmerican |
6.295600E-01 |
| Caucasian-vs-Asian |
2.602800E-01 |
| AfricanAmerican-vs-Asian |
3.562600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.69109999962281E-07 |
| Normal-vs-Female |
2.267200E-01 |
| Male-vs-Female |
5.835800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.716500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.037400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.428800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.488240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.129600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.615400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.239000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.809400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.761400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.288600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.469400E-01 |
| Normal-vs-Grade 2 |
1.417630E-01 |
| Normal-vs-Grade 3 |
8.026800000005E-05 |
| Normal-vs-Grade 4 |
1.70674585575625E-12 |
| Grade 1-vs-Grade 2 |
4.036400E-01 |
| Grade 1-vs-Grade 3 |
4.367600E-02 |
| Grade 1-vs-Grade 4 |
3.5309000000483E-06 |
| Grade 2-vs-Grade 3 |
1.051710E-02 |
| Grade 2-vs-Grade 4 |
2.30999663841658E-11 |
| Grade 3-vs-Grade 4 |
6.65630000007411E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.138400E-01 |
| Normal-vs-ccB subtype |
4.59979999645199E-08 |
| ccA subtype-vs-ccB subtype |
1.74500000005295E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.158500E-03 |
| Normal-vs-N1 |
4.44940000000615E-05 |
| N0-vs-N1 |
3.324400E-02 |
|
|
